Current Report Filing (8-k)
November 15 2017 - 4:49PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
|
Date of Report (Date of Earliest Event Reported):
|
|
November 8, 2017
|
CME Group Inc.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-31553
|
|
36-4459170
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
|
|
|
20 South Wacker Drive, Chicago, Illinois
|
|
|
|
60606
|
(Address of principal executive offices)
|
|
|
|
(Zip Code)
|
Registrants telephone number, including area code: 312-930-1000
Not Applicable
Former
name or former address, if changed since last report
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this
chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.03
|
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
|
On November 8, 2017, the
Board of Directors (the Board) of CME Group Inc. (the Company) amended and restated the Companys Bylaws (as so amended and restated, the Bylaws) to provide the Lead Director with the authority to call a
Special Meeting of the Board and to preside over meetings of the Board of Directors in the absence of the Chairman.
The foregoing description of the
amendments to the Bylaws is a summary only and is qualified in its entirety by reference to the full text of the Bylaws, a copy of which is included as Exhibit 3.1 to this report.
Item 9.01
|
Financial Statements and Exhibits.
|
A copy of the Fourteenth Amended and Restated Bylaws of CME Group
Inc., effective as of November 8, 2017, is filed as
Exhibit 3.1
to this report and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CME Group Inc.
|
|
|
|
|
November 15, 2017
|
|
|
|
By:
|
|
/s/ Kathleen M. Cronin
|
|
|
|
|
|
|
Name: Kathleen M. Cronin
|
|
|
|
|
|
|
Title: Senior Managing Director, General Counsel & Assistant Corporate Secretary
|
CME (NASDAQ:CME)
Historical Stock Chart
From Mar 2024 to Apr 2024
CME (NASDAQ:CME)
Historical Stock Chart
From Apr 2023 to Apr 2024